Mark Coleman - 03 Jan 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role: Director
Signature: /s/ Herriot Tabuteau, M.D., Attorney-in-Fact
Issuer symbol: AXSM
Transactions as of: 03 Jan 2025
Net transactions value: +$82,143
Form type: 4
Filing time: 06 Jan 2025, 16:06:29 UTC
Previous filing: 20 Nov 2024
Next filing: 20 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXSM	Common Stock	Options Exercise	$82,143	+9,127	+19%	$9.00	57,137	03 Jan 2025	Direct	F1
holding	AXSM	Common Stock						403,856	03 Jan 2025	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXSM	Stock Option (Right to Buy)	Options Exercise	$0	-9,127	-100%	$0.000000	0	03 Jan 2025	Common Stock	9,127	$9.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the exercise of stock options prior to expiration for cash and hold of underlying shares.
F2	Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.